These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22572237)

  • 1. Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung.
    Ryuge S; Sato Y; Jiang SX; Wang G; Matsumoto T; Katono K; Inoue H; Iyoda A; Satoh Y; Yoshimura H; Masuda N
    Lung Cancer; 2012 Aug; 77(2):415-20. PubMed ID: 22572237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
    Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma.
    Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G
    Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma.
    Hiroshima K; Iyoda A; Shibuya K; Haga Y; Toyozaki T; Iizasa T; Nakayama T; Fujisawa T; Ohwada H
    Cancer; 2004 Mar; 100(6):1190-8. PubMed ID: 15022286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of nestin expression in resected non-small cell lung cancer.
    Ryuge S; Sato Y; Wang GQ; Matsumoto T; Jiang SX; Katono K; Inoue H; Satoh Y; Masuda N
    Chest; 2011 Apr; 139(4):862-869. PubMed ID: 20829334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
    Ryuge S; Sato Y; Nagashio R; Hiyoshi Y; Katono K; Igawa S; Nakashima H; Shiomi K; Ichinoe M; Murakumo Y; Saegusa M; Satoh Y; Masuda N
    PLoS One; 2017; 12(3):e0173886. PubMed ID: 28358810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary large cell neuroendocrine carcinoma: its place in the spectrum of pulmonary carcinoma.
    Iyoda A; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2007 Aug; 84(2):702-7. PubMed ID: 17643676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour and survival of high-grade neuroendocrine carcinomas of the lung.
    Naranjo Gómez JM; Gómez Román JJ
    Respir Med; 2010 Dec; 104(12):1929-36. PubMed ID: 20810262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress protein Hsp27 expression predicts the outcome in operated small cell lung carcinoma and large cell neuroendocrine carcinoma patients.
    Marinova DM; Slavova YG; Trifonova N; Kostadinov D; Maksimov V; Petrov D
    J BUON; 2013; 18(4):915-20. PubMed ID: 24344017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Tsutsui H; Ohira T; Ikeda N
    Lung Cancer; 2011 Jun; 72(3):355-9. PubMed ID: 21075474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differences of biological behavior based on the clinicopathological data between resectable large-cell neuroendocrine carcinoma and small-cell lung carcinoma.
    Kinoshita T; Yoshida J; Ishii G; Aokage K; Hishida T; Nagai K
    Clin Lung Cancer; 2013 Sep; 14(5):535-40. PubMed ID: 23792008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases.
    Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K
    Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of large cell neuroendocrine histology in patients with pathologic stage Ia pulmonary non-small cell carcinoma.
    Iyoda A; Hiroshima K; Moriya Y; Sekine Y; Shibuya K; Iizasa T; Nakatani Y; Fujisawa T
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):312-5. PubMed ID: 16872955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large cell neuroendocrine carcinoma: an aggressive form of non-small cell lung cancer.
    Battafarano RJ; Fernandez FG; Ritter J; Meyers BF; Guthrie TJ; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):166-72. PubMed ID: 15999058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
    Shimada Y; Niho S; Ishii G; Hishida T; Yoshida J; Nishimura M; Yoh K; Goto K; Ohmatsu H; Ohe Y; Nagai K
    Lung Cancer; 2012 Mar; 75(3):368-73. PubMed ID: 21920624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of nestin in lymph node metastasis and lymphangiogenesis in non-small cell lung cancer patients.
    Chen Z; Wang T; Luo H; Lai Y; Yang X; Li F; Lei Y; Su C; Zhang X; Lahn BT; Xiang AP
    Hum Pathol; 2010 May; 41(5):737-44. PubMed ID: 20132963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.